Hu X et al., 2024-01: Review of the mechanisms reported for ivermectin against glioma, including PAK1/Akt/mTOR, autophagy, apoptosis and stem-cell effects, with a discussion of the obstacles to clinical use.
It can suppress the growth of various cancer cells, including glioma, through a multitude of mechanisms such as selective targeting of tumor-specific proteins, inducing programmed cell death, and modulation of tumor-related signaling pathways.
n/a (PubMed abstract)
Hu X et al., 2024-01: Review of the mechanisms reported for ivermectin against glioma, including PAK1/Akt/mTOR, autophagy, apoptosis and stem-cell effects, with a discussion of the obstacles to clinical use. Study type: narrative review. N: not stated. Country: China (West China Hospital, Sichuan University). Dose/route/schedule: n/a. Funder: Sichuan Province Science and Technology Supportive Project 2022YFS0049. COI: not stated in the record. Comparator: n/a. Study type: review.
